Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
Active, not recruiting · NCT03289299 · Registry updated 2023-12-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy, neoplasm, plasma cell neoplasm, precancerous condition, smoldering plasma cell myeloma | Active, not recruiting | Phase 2 | 2023-12-12 | NCT03289299 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
| Celgene | 53 |
| International Myeloma Foundation | 1 |
| Janssen Scientific Affairs, LLC | 37 |
| Trevie, Inc. | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Indiana University Simon Cancer Center | Indianapolis | United States | 9 |
| Levine Cancer Institute | Charlotte | United States | 110 |
| Mayo Clinic | Rochester | United States | 664 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Swedish Cancer Institute | Seattle | United States | 67 |
| University of Chicago Medical Center | Chicago | United States | 152 |
| University of Kansas Cancer Center | Westwood | United States | 36 |
| University of Maryland Medical Center | Baltimore | United States | 87 |
| Weill Cornell Medicine | New York | United States | 8 |